Viveon Health Acquisition (Viveon Health Acquisition) ROCE % : 72.09% (As of Dec. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Viveon Health Acquisition ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Viveon Health Acquisition's annualized ROCE % for the quarter that ended in Dec. 2022 was 72.09%.

Viveon Health Acquisition ROCE % Historical Data

The historical data trend for Viveon Health Acquisition's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viveon Health Acquisition ROCE % Chart

Viveon Health Acquisition Annual Data

Trend

Dec20

Dec21

Dec22

ROCE %

1.22

3.00

Viveon Health Acquisition Quarterly Data
	Aug20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
ROCE %	Get a 7-Day Free Trial				-0.99	-4.52	5.84	-13.34	72.09

Viveon Health Acquisition ROCE % Calculation

Viveon Health Acquisition's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	3.22	/	( ( (203.697 - 2.188)	+	(53.923 - 40.91) )	/ 2 )
	=	3.22	/	( (201.509	+	13.013)	/ 2 )
	=	3.22	/	107.261
	=	3.00 %

Viveon Health Acquisition's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2022 )		(Q: Sep. 2022 )		(Q: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2022 )		(Q: Sep. 2022 )		(Q: Dec. 2022 )
	=	22.232	/	( ( (53.155 - 4.493)	+	(53.923 - 40.91) )	/ 2 )
	=	22.232	/	( ( 48.662	+	13.013 )	/ 2 )
	=	22.232	/	30.8375
	=	72.09 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2022) EBIT data.

Viveon Health Acquisition (OTCPK:VHAQU) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Viveon Health Acquisition ROCE % Related Terms

Thank you for viewing the detailed overview of Viveon Health Acquisition's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Viveon Health Acquisition (Viveon Health Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Viveon Health Acquisition Corp (OTCPK:VHAQU) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3480 Peachtree Road NE, 2nd Floor, Suite 112, Atlanta, GA, USA, 30326

Website

Viveon Health Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses.

Executives

Demetrios G. Logothetis	director	C/O GIBSON, DEAL & FLETCHER, PC, 3953, NORCROSS GA 30092
Lishan Aklog	director	420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10171
Romilos Papadopoulos	director, 10 percent owner, officer: CFO and Treasurer	C/O XETHANOL CORPORATION, 3348 PEACHTREE ROAD NE, BLDG 200, #250, ATLANTA GA 30326
John Douglas Craft	director	C/O GIDSON, DEAL & FLETCHER, PC, 3953 HOLCOMB BRIDGE ROAD, NORCROSS GA 30092
Brian J. Cole	director	C/O GIBSON, DEAL, AND FLETCHER, P. C., 3953 HOLCOMB BRIDGE ROAD, NORCROSS GA 30092
Jagi Gill	director, 10 percent owner, officer: CEO and President	C/O GIDSON, DEAL & FLETCHER, PC, 395, NORCROSS GA 30092
Viveon Health, Llc	10 percent owner	C/O GIDSON, DEAL & FLETCHER, PC, 39, NORCROSS NY 30092